ArticleJTCVS structural and endovascular2026
Early-term and midterm outcomes of endovascular completion of high-risk subacute and early chronic residual dissection after type A repair.
Article in JTCVS structural and endovascular, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Late mortality, progressive aneurysmal degeneration, and major reinterventions remain frequent after repair of type A aortic dissection. This study aimed to evaluate early- and midterm outcomes of endovascular completion in patients with high-risk residual dissection treated during the subacute or early chronic phase. Methods: This study was a single-center retrospective analysis of a prospectively maintained institutional database. All consecutive patients undergoing endovascular completion for high-risk residual aortic dissection after type A dissection repair between January 2017 and September 2025 were included. Completion was performed using thoracic endovascular aortic repair alone or combined with the stented-assisted balloon-induced intimal disruption and relamination technique when distal extension exceeded Ishimaru zone 5. Primary outcomes were 30-day mortality and morbidity, as well as 3- and 5-year survival and reintervention rates. Results: Among 127 patients surviving initial type A repair, 48 (37.8%) underwent endovascular completion (subacute n = 33; early chronic n = 15). No 30-day deaths occurred, and technical success was achieved in all cases. Major adverse events occurred in 6.2%, with no spinal cord ischemia. Five patients (10.4%) required early reintervention. Median clinical follow-up was 54 months. Estimated survival was 97.9% at 3 years and 90.3% at 5 years. Freedom from major reintervention was 93.5% at 3 years and 89.1% at 5 years. False lumen thrombosis was achieved in 89.6% of thoracic and 81.4% of visceral segments. Conclusions: Endovascular completion of high-risk residual dissection after type A repair is safe and effective, providing excellent midterm survival, low major reintervention rates, and high rates of aortic remodeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.